Clinical utility of serum S100 in the therapy monitoring of patients with high risk malignant melanoma.

被引：0
|
作者：
Molina, R. [1 ]
Auge, J. M. [1 ]
Domingo, J. [1 ]
Puig, S. [1 ]
Filella, X. [1 ]
Malvehy, J. [1 ]
Castel, T. [1 ]
机构：
[1] T Castel Biochem & Genet Hosp Clin, IDIBAPS, Barcelona, Spain
来源：
TUMOR BIOLOGY | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical utility of serum S 100 and MIA in the therapy monitoring of patients with high risk malignant melanoma
    Auge, Josep Maria
    Molina, R.
    Domingo, J.
    Puig, S.
    Filella, X.
    Malvehy, J.
    Castel, T.
    Ballesta, A. M.
    TUMOR BIOLOGY, 2006, 27 : 43 - 43
  • [2] Evaluation of the Elecsys S100 immumoassay in patients with malignant melanoma.
    Alber, B
    Hein, R
    Luppa, P
    CLINICAL CHEMISTRY, 2004, 50 (06) : A78 - A78
  • [3] Clinical value of S100 levels in serum of malignant melanoma patients
    Natalia, S.
    Sergeeva, N. V.
    Marshutina, M. P.
    Mishunina, T. N.
    Lasutina, D. D.
    TUMOR BIOLOGY, 2007, 28 : 105 - 105
  • [4] S100 IRMA: A new and prognostic tumor marker in patients with malignant melanoma.
    Brenner, W
    Hauschild, A
    Engel, G
    Bohuslavizki, KH
    Monig, H
    Christophers, E
    Henze, E
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 600 - 600
  • [5] CLINICAL-SIGNIFICANCE OF SERUM S100 IN METASTATIC MALIGNANT-MELANOMA
    GUO, HB
    STOFFELWAGNER, B
    BIERWIRTH, T
    MEZGER, J
    KLINGMULLER, D
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (06) : 924 - 928
  • [6] Serum S100β protein as a marker of disease activity in patients with malignant melanoma
    Mohammed, MQ
    Abraha, HD
    Sherwood, RA
    MacRae, K
    Retsas, S
    MEDICAL ONCOLOGY, 2001, 18 (02) : 109 - 120
  • [7] Serum protein S100β in patients with malignant melanoma detected by an immunoluminometric assay
    Uwe Wollina
    Kerstin Karte
    Uta-Christina Hipler
    Brunhilde Knöll
    Karsten Kirsch
    Claudia Herold
    Journal of Cancer Research and Clinical Oncology, 2000, 126 : 107 - 110
  • [8] Serum S100β protein as a marker of disease activity in patients with malignant melanoma
    Mohammed M.Q.
    Abraha H.D.
    Sherwood R.A.
    MacRae K.
    Retsas S.
    Medical Oncology, 2001, 18 (2) : 109 - 120
  • [9] Serum protein S100β in patients with malignant melanoma detected by an immunoluminometric assay
    Wollina, U
    Karte, K
    Hipler, UC
    Knöll, B
    Kirsch, K
    Herold, C
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (02) : 107 - 110
  • [10] S100 protein serum levels in cutaneous malignant melanoma
    Seregni, E
    Massaron, S
    Martinetti, A
    Illeni, MT
    Rovini, D
    Belli, F
    Agresti, R
    Greco, M
    Cascinelli, N
    Bombardieri, E
    ONCOLOGY REPORTS, 1998, 5 (03) : 601 - 604
12345